Regulation of the phosphatase calcineurin by insulin-like growth factor i unveils a key role of astrocytes in Alzheimer's pathology

Molecular Psychiatry

Volumn 17, Issue 7, 2012, Pages 705-718

  Fernandez, A M ^a   Jimenez, S ^b   Mecha, M ^a   Davila D ^a   Guaza, C ^a   Vitorica, J ^b   Torres Aleman, I ^a  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Alzheimer; calcineurin; insulin like growth factor I

Indexed keywords

CALCINEURIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SOMATOMEDIN C; TRANSCRIPTION FACTOR FKHRL1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BRAIN; CALCINEURIN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; INSULIN-LIKE GROWTH FACTOR I; MAZE LEARNING; MICE; MICE, TRANSGENIC; NF-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PHOSPHORYLATION; PLAQUE, AMYLOID; RECOGNITION (PSYCHOLOGY); SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862776164     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.128     Document Type: Article

References (46)

1. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 2002; 8: 1390-1397. (Pubitemid 36019424)
2. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 2005; 7: 63-80. (Pubitemid 40387185)
3. Cohen E, Paulsson JF, Blinder P, Burstyn-Cohen T, Du D, Estepa G et al. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell 2009; 139: 1157-1169.
4. Freude S, Hettich MM, Schumann C, Stöhr O, Koch L, Köhler C et al. Neuronal IGF-1 resistance reduces A{beta} accumulation and protects against premature death in a model of Alzheimer's disease. FASEB J 2009; 23: 3315-3324.
5. Pons S, Torres-Aleman I. Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B). J Biol Chem 2000; 275: 38620-38625. (Pubitemid 32009191)
6. Fernandez AM, Fernandez S, Carrero P, Garcia-Garcia M, Torres-Aleman I. Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J Neurosci 2007; 27: 8745-8756. (Pubitemid 47292768)
7. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421. (Pubitemid 30349107)
8. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J Neurosci 2010; 30: 16755-16762.
9. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron 2001; 32: 177-180. (Pubitemid 33030186)
10. Remarque EJ, Bollen EL, Weverling-Rijnsburger AW, Laterveer JC, Blauw GJ, Westendorp RG. Patients with Alzheimer's disease display a pro-inflammatory phenotype. Exp Gerontol 2001; 36: 171-176. (Pubitemid 32012574)
11. Carrascosa C, Torres-Aleman I, Lopez-Lopez C, Carro E, Espejo L, Torrado S et al. Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration. Biomaterials 2004; 25: 707-714. (Pubitemid 37357284)
12. Trejo JL, Piriz J, Llorens-Martin MV, Fernandez AM, Bolós M, LeRoith D et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 2007; 12: 1118-1128. (Pubitemid 350191366)
13. Sarter M, Bodewitz G, Stephens DN. Attenuation of scopolamineinduced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist beta-carbolines. Psychopharmacology (Berl) 1988; 94: 491-495. (Pubitemid 18087398)
14. Carro E, Trejo JL, Gerber A, Loetscher H, Torrado J, Metzger F et al. Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis. Neurobiol Aging 2006; 27: 1250-1257. (Pubitemid 44088577)
15. Wilk A, Urbanska K, Yang S, Ying Wang J, Amini S, Del Valle L et al. Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-alphamediated neuronal damage: implications for human immunodeficiency virus encephalitis. J Neurosci Res 2011; 89: 183-198.
16. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868. (Pubitemid 29165088)
17. Lara-Pezzi E, Winn N, Paul A, McCullagh K, Slominsky E, Santini MP et al. A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration. J Cell Biol 2007; 179: 1205-1218. (Pubitemid 350277739)
18. Tremblay ML, Giguere V. Phosphatases at the heart of FoxO metabolic control. Cell Metabo 2008; 7: 101-103. (Pubitemid 351168562)
19. Glass CK, Ogawa S. Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 2006; 6: 44-55. (Pubitemid 43279752)
20. Glass CK, Saijo K,Winner B,Marchetto MC, Gage FH.Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918-934.
21. Benzing WC, Wujek JR, Ward EK, Shaffer D, Ashe KH, Younkin SG et al. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 1999; 20: 581-589. (Pubitemid 30064403)
22. Moloney AM, Griffin RJ, Timmons S, O'Connor R, Ravid R, O'Neill C. Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling. Neurobiol Aging 2010; 31: 224-243.
23. He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C et al. Deletion of tumor necrosis factor death receptor inhibits amyloid {beta} generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 2007; 178: 829-841. (Pubitemid 47347367)
24. Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 2009; 323: 1211-1215.
25. Otsuka N, Tomonaga M, Ikeda K. Rapid appearance of betaamyloid precursor protein immunoreactivity in damaged axons and reactive glial cells in rat brain following needle stab injury. Brain Res 1991; 568: 335-338.
26. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695. (Pubitemid 23350687)
27. Hata R, Masumura M, Akatsu H, Li F, Fujita H, Nagai Y et al. Upregulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. Biochem Biophys Res Commun 2001; 284: 310-316. (Pubitemid 32917976)
28. Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K, Gong CX. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 2005; 280: 37755-37762. (Pubitemid 41642385)
29. Lian Q, Ladner CJ, Magnuson D, Lee JM. Selective changes of calcineurin (protein phosphatase 2B) activity in Alzheimer's disease cerebral cortex. Exp Neurol 2001; 167: 158-165. (Pubitemid 32066418)
30. Norris CM, Kadish I, Blalock EM, Chen KC, Thibault V, Porter NM et al. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J Neurosci 2005; 25: 4649-4658. (Pubitemid 40629156)
31. Abdul HM, Sama MA, Furman JL, Mathis DM, Beckett TL, Weidner AM et al. Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci 2009; 29: 12957-12969.
32. D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A et al. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 2011; 14: 69-76.
33. Reese LC, Zhang W, Dineley KT, Kayed R, Taglialatela G. Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell 2008; 7: 824-835. (Pubitemid 352749437)
34. Calnan DR, Brunet A. The FoxO code. Oncogene 2008; 27: 2276-2288. (Pubitemid 351501779)
35. Ni YG, Wang N, Cao DJ, Sachan N, Morris DJ, Gerard RD et al. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc Natl Acad Sci 2007; 104: 20517-20522.
36. Shioda N, Fukunaga K. [The functional roles of constitutively active calcineurin in delayed neuronal death after brain ischemia]. Yakugaku Zasshi 2011; 131: 13-20.
37. Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain 2005; 128: 1442-1453. (Pubitemid 40826196)
38. Delerive P, De Bosscher K, Besnard S, Vanden BergheW, Peters JM, Gonzalez FJ et al. Peroxisome proliferator-activated receptor +' negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-+'B and AP-1. J Biol Chem 1999; 274: 32048-32054.
39. Gareau JR, Lima CD. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol 2010; 11: 861-871.
40. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry 2005; 13: 950-958. (Pubitemid 46638661)
41. Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M et al. Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study. Dement Geriatr Cogn Disord 2010; 30: 131-146.
42. Dineley KT, Hogan D, Zhang WR, Taglialatela G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem 2007; 88: 217-224. (Pubitemid 47223751)
43. Alfieri CM, Evans-Anderson HJ, Yutzey KE. Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle. Am J Physiol Cell Physiol 2007; 292: C1887-C1894. (Pubitemid 47080553)
44. Chen DY, Stern SA, Garcia-Osta A, Saunier-Rebori B, Pollonini G, Bambah-Mukku D et al. A critical role for IGF-II in memory consolidation and enhancement. Nature 2011; 469: 491-497.
45. Adlerz L, Holback S, Multhaup G, Iverfeldt K. IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J Biol Chem 2007; 282: 10203-10209. (Pubitemid 47093446)
46. Boucher J, Macotela Y, Bezy O, Mori MA, Kriauciunas K, Kahn CR. A kinase-independent role for unoccupied insulin and IGF-1 receptors in the control of apoptosis. Sci Signal 2010; 3: ra87.